Prof Dr. Mahmoud Ahmed, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia
Professional Profiles
Google Scholar
Scopus
Orcid
šAcademic Qualifications
Dr. Mahmoud Ahmed Mansour completed his PhD in Physiological Chemistry from Karolinska Institutet, Stockholm, Sweden, between 1990 and 1993. His thesis focused on leukotrienes and lipoxins, particularly investigating the role of Leukotrienes C4 and B4 in chronic myeloid leukemia. Prior to that, he earned his Master’s degree in Biochemistry from Al-Azhar University, Cairo-Egypt, where his research centered on the role of steroidal hormones in breast cancer (1987-1990). He also obtained a Diploma in Biochemical Analysis from Al-Azhar University (1985-1986), and graduated with a Bachelor of Pharmaceutical Sciences with Honors from the Faculty of Pharmacy, Al-Azhar University, in 1984.
š©āš«Academic ExperienceĀ
Dr. Mansour has extensive academic experience spanning several prestigious universities. Since 2012, he has served as a Professor of Pharmaceutical Sciences at the King Saud bin Abdulaziz University for Health Sciences (KSAU-HS). From 2006 to 2012, he was a Professor in the Pharmacology Department at King Saud University (KSU). Additionally, he held the position of Professor of Pharmacology at King Faisal University (2005-2006) and was an Associate Professor in Biochemistry at Al-Azhar University from 2002 to 2005. Earlier in his career, he served as an Assistant Professor in both King Saud University and Al-Azhar University, where he taught a variety of courses in biochemistry, pharmacology, and clinical chemistry.
š¬Research Interests
Dr. Mansourās research has contributed significantly to several fields of biochemistry and pharmacology. His primary interests include:
Leukotrienes and Lipoxins: Investigating their synthesis, quantitation, and biological effects.
Oxidative Damage and Free Radicals: Studying their role in tissue injury, aging, and cancer prevention.
Tumor Markers: Researching biomarkers for the early diagnosis of cancer.
Molecular Biology: Focusing on genetic techniques and oncogenic transformations.
Chemical Toxicities: Exploring biochemical changes related to aging and disease.
š§ŖInstrumental Expertise
Throughout his career, Dr. Mansour has gained substantial expertise in various laboratory techniques and instrumentation. These include spectrophotometry, high-performance liquid chromatography (HPLC), flow cytometry, PCR, enzyme-linked immunosorbent assays (ELISA), and tissue culture. His work in animal experimentation covers fields such as induced liver damage, diabetes, hyperlipidemia, and tumors. He has also developed proficiency in ultracentrifugation, electrophoresis, and atomic absorption techniques.
š
Honors and Awards
Dr. Mansour has been recognized with several honors and awards throughout his distinguished career. In 1983, he received a Travel Award to attend the International Pharmaceutical Students Federation Conference in Lausanne, Switzerland. In 1998, he was awarded the prestigious State Encouragement Award in Medical Sciences, recognizing his contributions to the field of biochemistry and pharmacology.
šØāš«Teaching Contributions
Dr. Mansour has been a dedicated educator for undergraduate and graduate students across multiple institutions. He has taught courses in Biochemistry, Pharmacology, Toxicology, Clinical Chemistry, and Pharmacogenomics. He has served on examination boards for undergraduates and postgraduates at various faculties of pharmacy in Egypt, and has contributed to curriculum development and student progress committees at KSAU-HS.
š„ļøComputer Skills
Dr. Mansour is highly proficient in a range of computer applications, including MS Windows, Mac OSX, and various academic tools like MS Publisher, MS Office, and Adobe Acrobat Pro. He also possesses advanced knowledge of the internet and emerging technologies that are applicable to academia, such as the iPad and smart pens.
šPublications Top Noted
A possible antineoplastic potential of selective, irreversible proteasome inhibitor, carfilzomib on chemically induced hepatocarcinogenesis in rats
Authors: Mansour, M.A., Aljoufi, M.A., Al-Hosaini, K., Al-Rikabi, A.C., Nagi, M.N.
Journal: Journal of Biochemical and Molecular Toxicology
Year: 2014
Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma
Authors: Mansour, M.A., Aljoufi, M.A., Al-Hosaini, K., Al-Rikabi, A.C., Nagi, M.N.
Journal: Chemico-Biological Interactions
Year: 2014
Evaluation of oxidative stress and antioxidant status in diabetic and hypertensive women during labor
Authors: Al-Shebly, M.M., Mansour, M.A.
Journal: Oxidative Medicine and Cellular Longevity
Year: 2012
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver
Authors: Mansour, M.A., Al-Ismaeel, H., Al-Rikabi, A.C., Al-Shabanah, O.A.
Journal: Life Sciences
Year: 2011
Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression
Authors: Alhaider, A.A., Korashy, H.M., Sayed-Ahmed, M.M., Kfoury, H., Mansour, M.A.
Journal: Chemico-Biological Interactions
Year: 2011
Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model
Authors: Mansour, M.A., Bekheet, S.A., Al-Rejaie, S.S., Al-Rikabi, A.C., Abdo, A.A.
Journal: BioFactors
Year: 2010